CathWorks Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
73
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$718M
CathWorks General Information
Description
Developer of a computational science platform designed to optimize therapy decisions. The company's platform provides a functional flow reserve for processing visual information and automatic multi-layered algorithms to improve the utilization of coronary angiography data to ratify measurement-based medicine, enabling healthcare providers to optimize cardiac catheterization laboratory throughput.
Contact Information
Website
www.cath.works(Operating Subsidiary)
Corporate Office
- 4000 MacArthur Boulevard
- Suite 1025-East Tower
- Newport Beach, CA 92660
- United States
Corporate Office
- 4000 MacArthur Boulevard
- Suite 1025-East Tower
- Newport Beach, CA 92660
- United States
CathWorks Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 20-Apr-2026 | $718M | Completed | Generating Revenue | ||
| 10. Later Stage VC | 12-Jul-2022 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Later Stage VC (Series D) | 16-Dec-2020 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 29-Jun-2020 | Completed | Generating Revenue | |||
| 6. Grant | 29-May-2019 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 04-Feb-2019 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jun-2018 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 01-Jan-2018 | $23.6M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series B) | 02-Oct-2017 | $16.3M | $23.6M | Completed | Generating Revenue |
CathWorks Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred D | ||||||||
| Preferred C | ||||||||
| Preferred B | ||||||||
| Preferred A4 | ||||||||
| Preferred A3 | ||||||||
| Preferred A2 | ||||||||
| Preferred A1 | 948 | $0.010000 | $150.84 | $150.84 | 1x | $150.84 | 0.53% | |
| Preferred A | 30,811 | $0.010000 | $189 | $189 | 1x | $189 | 17.27% |
CathWorks Comparisons
Industry
Financing
Details
CathWorks Competitors (5)
One of CathWorks’s 5 competitors is HeartFlow, a Formerly VC-backed company based in Mountain View, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| HeartFlow | Formerly VC-backed | Mountain View, CA | ||||
| Philips | Corporation | Amsterdam, Netherlands | ||||
| Boston Scientific | Corporation | Marlborough, MA | ||||
| Opsens | Corporate Backed or Acquired | Quebec, Canada | ||||
| Abbott | Corporation | Abbot Park, IL |
CathWorks Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CathWorks Patents
CathWorks Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026003787-A1 | User assist for vascular analysis and modeling | Pending | 28-Jun-2024 | ||
| US-12567489-B2 | Systems and methods for displaying distal fractional flow reserve values in vascular analysis | Active | 12-Jun-2024 | ||
| US-20250380913-A1 | Systems and methods for displaying distal fractional flow reserve values in vascular analysis | Active | 12-Jun-2024 | ||
| US-20260221247-A1 | Systems and methods for displaying distal fractional flow reserve values in vascular analysis | Pending | 12-Jun-2024 | ||
| WO-2025257749-A1 | Systems and methods for displaying vascular analysises | Pending | 12-Jun-2024 | G16H40/60 |
CathWorks Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CathWorks Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abiomed | Corporation | Minority | ||
| BioStar Capital | Venture Capital | Minority | ||
| Corundum Open Innovation | Venture Capital | Minority | ||
| Deerfield Management | Venture Capital | Minority | ||
| Innovation Authority | Government |
CathWorks FAQs
-
When was CathWorks founded?
CathWorks was founded in 2013.
-
Where is CathWorks headquartered?
CathWorks is headquartered in Newport Beach, CA.
-
What is the size of CathWorks?
CathWorks has 73 total employees.
-
What industry is CathWorks in?
CathWorks’s primary industry is Decision/Risk Analysis.
-
Is CathWorks a private or public company?
CathWorks is a Private company.
-
What is the current valuation of CathWorks?
The current valuation of CathWorks is .
-
What is CathWorks’s current revenue?
The current revenue for CathWorks is .
-
How much funding has CathWorks raised over time?
CathWorks has raised $159M.
-
Who are CathWorks’s investors?
Abiomed, BioStar Capital, Corundum Open Innovation, Deerfield Management, and Innovation Authority are 5 of 12 investors who have invested in CathWorks.
-
Who are CathWorks’s competitors?
HeartFlow, Philips, Boston Scientific, Opsens, and Abbott are competitors of CathWorks.
-
When was CathWorks acquired?
CathWorks was acquired on 20-Apr-2026.
-
Who acquired CathWorks?
CathWorks was acquired by Medtronic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
